20 years of taxane therapy in prostate cancer - the past, present and future.

Carceles-Cordon M, Rodriguez-Bravo V, Petrylak DP, Domingo-Domenech J

Open source

DOI
10.1038/s41585-025-01104-9
Published
2026 Jun
Container
Nature reviews. Urology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41585-025-01104-9,
  title = {20 years of taxane therapy in prostate cancer - the past, present and future.},
  author = {Carceles-Cordon M and Rodriguez-Bravo V and Petrylak DP and Domingo-Domenech J},
  year = {2026},
  journal = {Nature reviews. Urology},
  doi = {10.1038/s41585-025-01104-9},
  url = {https://doi.org/10.1038/s41585-025-01104-9}
}

RIS

TY  - JOUR
TI  - 20 years of taxane therapy in prostate cancer - the past, present and future.
AU  - Carceles-Cordon M
AU  - Rodriguez-Bravo V
AU  - Petrylak DP
AU  - Domingo-Domenech J
PY  - 2026
JO  - Nature reviews. Urology
DO  - 10.1038/s41585-025-01104-9
UR  - https://doi.org/10.1038/s41585-025-01104-9
ER  - 

APA

M, C., V, R., DP, P., & J, D. (2026). 20 years of taxane therapy in prostate cancer - the past, present and future.. Nature reviews. Urology. https://doi.org/10.1038/s41585-025-01104-9

Source records